Legal & Regulatory

Change.org touts its influence in the decision

DEA’s manufacturer and distributor data-collection requirements are changing

Sample management is just one of many focus areas for sales operations

Licensing for Gilead’s Truvada and Descovy products is in question

Action expands Pharma Logistics’ leadership in servicing independent pharmacies

Task force report highlights the economic disincentives of short-supply products

New group will coordinate end-to-end supply chain practices in the US

Upstart organization seeks to create another pathway for acceptance by regulators and pharmacy benefit managers

Certification of its Itasca, IL central control tower

Trading partners will have until November 2020 to get their IT systems into operation

A critical time for carrying DSCSA forward

Provider offers absorbents to manage hazardous drug cleanup

Updated prospectus proposes membership rules, budget and leadership

A changed look but not a changed direction

HHS Azar announces a plan to make a plan, roughly in time to be a talking point in next year’s national election

HDA Research Foundation highlights constraints and additional costs of reimportation

News follows court ruling against advertising retail drug prices

CDER activity is one of the few exceptions

Cross-contamination and missing documentation are cited in warning letters

Meanwhile, federal enforcement actions over improper patient assistance continue to arise

Investigative journalist Katherine Eban returns with an indictment of generic drug quality

Association will promote its members' value to the public via digital advertising and publishing